The cumulative prevalence of diabetes and pre-diabetes in the US is now a staggering 40%. Deficiencies of islet ? cell mass and/or function are paramount in the transition from impaired glucose tolerance to frank diabetes in virtually all forms of diabetes, and such deficiencies emanate from pathways contributing to inflammatory, ER, and oxidative stress among others. In this renewal application, we will focus on a novel pathway we identified during the past funding cycle that appears to regulate the translational responses to stress in the ? cell. Eukaryotic translation initiation factor 5A (eIF5A) and its rate-limiting modifying enzyme deoxyhypusine synthase (DHS) are highly conserved proteins that, together, are responsible for the shuttling and translational elongation of specific inflammation- and ER stress-induced transcripts in ? cells. Strikingly, it appears that eIF5A depends exclusively upon DHS for its crucial post-translational modification (known as hypusination) and, reciprocally, the only known substrate for DHS is eIF5A. We believe DHS and eIF5A function together in a pathway that regulates the balance between the translation of emergency proteins for the adaptive response to stress, and the translation of proteins that initiate cellular execution when stress proceeds unabated. We hypothesize that ? cell stress pathways in type 2 diabetes are promoted at the translational elongation level by the actions of DHS and eIF5A. We believe, as a research group, we are uniquely positioned with the biochemical and islet expertise, and a comprehensive set of reagents--including conventional and conditional KO mice, in vivo RNA interference technologies--to test this hypothesis. We propose the following 3 integrated aims:
Aim 1 : Identify the molecular mechanisms by which DHS/eIF5A promotes the production of stress- responsive proteins in islet ? cells.
Aim 2 : Determine the regulatory mechanisms underlying the reciprocal compartmentation of DHS and eIF5A in ? cells during acute stress.
Aim 3 : Determine the role of DHS/eIF5A in islet compensation and dysfunction in mouse models of diabetes and inflammation. We believe the major impact of these studies will be to establish a fundamental new post-transcriptional paradigm in the study of inflammatory and ER stress responses that may be applicable in a wide variety of cell types relevant to diabetes pathogenesis.

Public Health Relevance

Diabetes is a disorder of insulin-producing and insulin-responsive cells that afflicts 24 million Americans, and its incidence is rising at an alarming rate. The specific goal of this grant is to investigate how the islet ? cell responds to stress, as seen in diabetes, at the mRNA translational level. Overall, this project seeks to understand how ? cells function to release insulin and how specific proteins allow for ? cells to respond appropriately or inappropriately to stress, with the hope that manipulating such proteins might lead to new therapy for diabetes.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
Cellular Aspects of Diabetes and Obesity Study Section (CADO)
Program Officer
Sato, Sheryl M
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Indiana University-Purdue University at Indianapolis
Schools of Medicine
United States
Zip Code
Mastracci, Teresa L; Turatsinze, Jean-Valery; Book, Benita K et al. (2018) Distinct gene expression pathways in islets from individuals with short- and long-duration type 1 diabetes. Diabetes Obes Metab 20:1859-1867
Mulukutla, Surya N; Tersey, Sarah A; Hampe, Christiane S et al. (2018) Elevated unmethylated and methylated insulin DNA are unique markers of A+?+ ketosis prone diabetes. J Diabetes Complications 32:193-195
Marasco, Michelle R; Conteh, Abass M; Reissaus, Christopher A et al. (2018) Interleukin-6 Reduces ?-Cell Oxidative Stress by Linking Autophagy With the Antioxidant Response. Diabetes 67:1576-1588
Sims, Emily K; Park, Grace; Mather, Kieren J et al. (2018) Immune reconstitution in ART treated, but not untreated HIV infection, is associated with abnormal beta cell function. PLoS One 13:e0197080
Beli, Eleni; Yan, Yuanqing; Moldovan, Leni et al. (2018) Restructuring of the Gut Microbiome by Intermittent Fasting Prevents Retinopathy and Prolongs Survival in db/db Mice. Diabetes 67:1867-1879
Sims, Emily K; Evans-Molina, Carmella; Tersey, Sarah A et al. (2018) Biomarkers of islet beta cell stress and death in type 1 diabetes. Diabetologia 61:2259-2265
Simons, Zachary B; Morgan, Rachel C; Rose, Laurel et al. (2018) Hypoglycemia in a Patient With a Polyhormonal Pancreatic Neuroendocrine Tumor With Evidence of Endocrine Progenitors. J Endocr Soc 2:172-177
Samala, Niharika; Tersey, Sarah A; Chalasani, Naga et al. (2017) Molecular mechanisms of nonalcoholic fatty liver disease: Potential role for 12-lipoxygenase. J Diabetes Complications 31:1630-1637
Blandino-Rosano, Manuel; Barbaresso, Rebecca; Jimenez-Palomares, Margarita et al. (2017) Loss of mTORC1 signalling impairs ?-cell homeostasis and insulin processing. Nat Commun 8:16014
Hatanaka, Masayuki; Anderson-Baucum, Emily; Lakhter, Alexander et al. (2017) Chronic high fat feeding restricts islet mRNA translation initiation independently of ER stress via DNA damage and p53 activation. Sci Rep 7:3758

Showing the most recent 10 out of 80 publications